JMP Group Inc (JMP) Fundamental Analysis & Valuation

NYSE:JMP

7.5
+0.02 (+0.27%)
At close: Nov 15, 2021
7.49
-0.01 (-0.13%)
After Hours: 11/15/2021, 8:51:24 PM

This JMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall JMP gets a fundamental rating of 2 out of 10. We evaluated JMP against 238 industry peers in the Capital Markets industry. Both the profitability and financial health of JMP have multiple concerns. JMP is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

0

1. JMP Profitability Analysis

1.1 Basic Checks

  • In the past year JMP was profitable.
JMP Yearly Net Income VS EBIT VS OCF VS FCFJMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 10M -10M 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 4.71%
ROE 15.12%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JMP Yearly ROA, ROE, ROICJMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 -5 -10 -15

1.3 Margins

Industry RankSector Rank
OM 9.63%
PM (TTM) 6.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JMP Yearly Profit, Operating, Gross MarginsJMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 20 40 60 80

0

2. JMP Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for JMP has been increased compared to 1 year ago.
  • The debt/assets ratio for JMP has been reduced compared to a year ago.
JMP Yearly Shares OutstandingJMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 5M 10M 15M 20M
JMP Yearly Total Debt VS Total AssetsJMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 200M 400M 600M 800M 1B

2.2 Solvency

  • JMP has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
JMP Yearly LT Debt VS Equity VS FCFJMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

7

3. JMP Growth Analysis

3.1 Past

  • JMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9800.00%, which is quite impressive.
  • Measured over the past years, JMP shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.33% on average per year.
  • The Revenue has grown by 99.21% in the past year. This is a very strong growth!
  • Measured over the past years, JMP shows a decrease in Revenue. The Revenue has been decreasing by -6.66% on average per year.
EPS 1Y (TTM)9800%
EPS 3Y-3.03%
EPS 5Y-6.33%
EPS Q2Q%123.08%
Revenue 1Y (TTM)99.21%
Revenue growth 3Y-7.62%
Revenue growth 5Y-6.66%
Sales Q2Q%58.42%

3.2 Future

  • Based on estimates for the next years, JMP will show a very strong growth in Earnings Per Share. The EPS will grow by 30.69% on average per year.
  • The Revenue is expected to grow by 29.95% on average over the next years. This is a very strong growth
EPS Next Y35.21%
EPS Next 2Y6.79%
EPS Next 3Y21.98%
EPS Next 5Y30.69%
Revenue Next Year65.99%
Revenue Next 2Y28.13%
Revenue Next 3Y29.13%
Revenue Next 5Y29.95%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JMP Yearly Revenue VS EstimatesJMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
JMP Yearly EPS VS EstimatesJMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

5

4. JMP Valuation Analysis

4.1 Price/Earnings Ratio

  • JMP is valuated cheaply with a Price/Earnings ratio of 7.58.
  • JMP is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 10.61 indicates a reasonable valuation of JMP.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. JMP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.58
Fwd PE 10.61
JMP Price Earnings VS Forward Price EarningsJMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.18
JMP Per share dataJMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • JMP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • JMP's earnings are expected to grow with 21.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y6.79%
EPS Next 3Y21.98%

0

5. JMP Dividend Analysis

5.1 Amount

  • JMP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

JMP Fundamentals: All Metrics, Ratios and Statistics

JMP Group Inc

NYSE:JMP (11/15/2021, 8:51:24 PM)

After market: 7.49 -0.01 (-0.13%)

7.5

+0.02 (+0.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)03-01
Inst Owners0%
Inst Owner Change0%
Ins Owners0.82%
Ins Owner Change0%
Market Cap157.82M
Revenue(TTM)174.43M
Net Income(TTM)10.65M
Analysts45
Price Target7.65 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.58
Fwd PE 10.61
P/S 0.9
P/FCF N/A
P/OCF N/A
P/B 2.24
P/tB N/A
EV/EBITDA 8.18
EPS(TTM)0.99
EY13.2%
EPS(NY)0.71
Fwd EY9.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.29
BVpS3.35
TBVpSN/A
PEG (NY)0.22
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 15.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.63%
PM (TTM) 6.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9800%
EPS 3Y-3.03%
EPS 5Y-6.33%
EPS Q2Q%123.08%
EPS Next Y35.21%
EPS Next 2Y6.79%
EPS Next 3Y21.98%
EPS Next 5Y30.69%
Revenue 1Y (TTM)99.21%
Revenue growth 3Y-7.62%
Revenue growth 5Y-6.66%
Sales Q2Q%58.42%
Revenue Next Year65.99%
Revenue Next 2Y28.13%
Revenue Next 3Y29.13%
Revenue Next 5Y29.95%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

JMP Group Inc / JMP FAQ

What is the ChartMill fundamental rating of JMP Group Inc (JMP) stock?

ChartMill assigns a fundamental rating of 5 / 10 to JMP.


Can you provide the valuation status for JMP Group Inc?

ChartMill assigns a valuation rating of 7 / 10 to JMP Group Inc (JMP). This can be considered as Undervalued.


Can you provide the profitability details for JMP Group Inc?

JMP Group Inc (JMP) has a profitability rating of 4 / 10.


What is the valuation of JMP Group Inc based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JMP Group Inc (JMP) is 7.58 and the Price/Book (PB) ratio is 2.24.


Can you provide the expected EPS growth for JMP stock?

The Earnings per Share (EPS) of JMP Group Inc (JMP) is expected to grow by 35.21% in the next year.